Eagle Asset Management Inc Novo Cure LTD Transaction History

Eagle Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $34.6 Million - $53.1 Million	-279,158 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $31.3 Million - $48.6 Million	279,158 New	279,158 $48.3 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $1.84 Million - $3.53 Million	-31,711 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $44.4 Million - $57.7 Million	-775,415 Reduced 96.07%	31,711 $1.83 Million
Q1 2020 May 11, 2020	SELL	$57.05 - $95.75 $375,274 - $629,843	-6,578 Reduced 0.81%	807,126 $54.4 Million
Q4 2019 Feb 07, 2020	SELL	$68.3 - $93.8 $287,543 - $394,898	-4,210 Reduced 0.51%	813,704 $68.6 Million
Q3 2019 Nov 04, 2019	BUY	$61.86 - $97.8 $41.2 Million - $65.1 Million	665,321 Added 436.01%	817,914 $61.2 Million
Q2 2019 Aug 05, 2019	BUY	$42.22 - $63.23 $6.44 Million - $9.65 Million	152,593 New	152,593 $9.65 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.